Multi-year Revenue Scale-upSustained multi-year revenue growth to A$7.6m demonstrates durable product-market fit and expanding commercial traction in aged-care and healthtech. A larger revenue base supports recurring subscription upsell, economies of scale and reduces execution risk versus early-stage peers over the next 2–6 months.
Improving Profitability And Positive EBITDAA shift to positive EBITDA and a sharp narrowing of net loss indicate the business is beginning to convert revenue scale into operating leverage. If sustained, this structural margin improvement improves cash generation prospects, supports future reinvestment, and strengthens negotiating position with partners.
Strategic Divestment To Strengthen Balance SheetThe sale of Embedded Health Solutions for A$5m is a structural change that both provides material cash and sharpens strategic focus on the HMR Referrals platform. Proceeds can de-lever the balance sheet, fund core product development, and reduce management distraction over the medium term.